BTG plc (LON:BTG)‘s stock had its “buy” rating reissued by research analysts at Stifel Nicolaus in a research report issued on Wednesday. They presently have a GBX 800 ($10.35) price target on the stock. Stifel Nicolaus’ price objective would suggest a potential upside of 16.36% from the company’s previous close.

A number of other analysts have also recently weighed in on BTG. Peel Hunt reaffirmed a “hold” rating and set a GBX 630 ($8.15) price objective on shares of BTG plc in a research report on Tuesday, May 16th. Panmure Gordon increased their price objective on BTG plc from GBX 737 ($9.53) to GBX 809 ($10.46) and gave the stock a “buy” rating in a research report on Tuesday, May 16th. Jefferies Group LLC reaffirmed a “buy” rating and set a GBX 775 ($10.02) price objective on shares of BTG plc in a research report on Tuesday, May 16th. Numis Securities Ltd reaffirmed a “buy” rating and set a GBX 900 ($11.64) price objective on shares of BTG plc in a research report on Tuesday, May 16th. Finally, J P Morgan Chase & Co decreased their price objective on BTG plc from GBX 790 ($10.22) to GBX 750 ($9.70) and set a “neutral” rating for the company in a research report on Wednesday, May 17th. Three investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of GBX 774.78 ($10.02).

Shares of BTG plc (LON:BTG) opened at 694.50 on Wednesday. The stock’s market cap is GBX 2.67 billion. BTG plc has a 52-week low of GBX 528.36 and a 52-week high of GBX 738.50. The stock’s 50 day moving average is GBX 662.22 and its 200 day moving average is GBX 639.49.

WARNING: This article was originally reported by Watch List News and is owned by of Watch List News. If you are accessing this article on another publication, it was illegally copied and republished in violation of US & international copyright & trademark law. The original version of this article can be viewed at https://www.watchlistnews.com/btg-plcs-btg-buy-rating-reiterated-at-stifel-nicolaus/1531302.html.

In other news, insider Rolf Soderstrom sold 22,624 shares of the firm’s stock in a transaction that occurred on Friday, June 9th. The stock was sold at an average price of GBX 649 ($8.39), for a total value of £146,829.76 ($189,898.81).

About BTG plc

BTG plc is engaged in the business of healthcare, focusing on Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care uses, and a licensing business. The Company operates through three segments: Interventional Medicine, Specialty Pharmaceuticals and Licensing.

Analyst Recommendations for BTG plc (LON:BTG)

Receive News & Ratings for BTG plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG plc and related companies with Analyst Ratings Network's FREE daily email newsletter.